'Forgotten' drug revisited as potential leukaemia treatment
23 February, 2023The drug, called PIK-75, was initially discovered over a decade ago but was dismissed in favour of newer ones.
$96m RNA facility coming to Macquarie University
22 February, 2023Myeloid Therapeutics will collaborate with the NSW Government to create a world-class RNA manufacturing and research facility at Macquarie University.
PrEP implant could enable long-term HIV protection
20 February, 2023Researchers have been collaborating on an injectable implant that can release HIV PrEP medications into the body over a long period of time, with promising results.
UQ vaccine to protect pigs from Japanese encephalitis virus
16 February, 2023UQ-developed chimera virus technology was used to make a 'hybrid' version of the virus, using a mosquito-only Australian virus that is harmless to humans.
Milestone as scientists regenerate diseased kidney
15 February, 2023Blocking a damaging and scar-regulating protein called interleukin-11 (IL-11) enables damaged kidney cells to regenerate, restoring impaired kidney function.
AcuraBio expands cGMP plasmid DNA CDMO services
14 February, 2023AcuraBio expects to produce more plasmid DNA for its customers around the world using Cytiva's latest bacterial plasmid two-step purification protocol.
2023 COVID-19 booster vaccine available for Aust adults
08 February, 2023Adults who have not had a COVID-19 booster or a confirmed case of COVID-19 in the past six months will soon be able to get another booster to give them additional protection.
TGA approves psychedelics for mental health treatment
06 February, 2023 by Lauren DavisFrom 1 July this year, the TGA will permit the prescribing of MDMA for post-traumatic stress disorder and psilocybin for treatment-resistant depression.
Artificial DNA kills cancer cells
26 January, 2023Researchers developed a chemically synthesised, hairpin-shaped DNA strand that can activate a natural immune response to target and kill specific cancerous cells.
Light therapy eliminates antibiotic-resistant superbugs
23 January, 2023The photodynamic technology harnesses the energy of light to generate highly reactive oxygen molecules that eradicate microbial cells and kill deadly bacteria.
Queensland invests in global mRNA vaccine hub
08 December, 2022Sanofi has partnered with the Queensland Government, The University of Queensland and Griffith University to inject $280 million into a next-generation mRNA vaccine research hub.
With funding dwindling, how can biotech companies maintain momentum?
06 December, 2022 by Glenn Bilawsky, CEOPartnering with biopharmaceutical outsourcing companies provides an opportunity for drug and diagnostic developers to better leverage their assets.
Gene therapy trial for type 1 diabetes to proceed
30 November, 2022The trial is set to be the first time that genetically engineered pancreatic islet cells will be transplanted into humans to treat type 1 diabetes.
$352m plasma therapeutics plant coming to Qld
29 November, 2022Aegros, which is currently based in Sydney, will establish its global headquarters and a one-million-litre plasma fractionation facility in Springfield's BioPark Australia precinct.
A second chance for UQ's molecular clamp vaccine platform
28 November, 2022UQ is set to take a second-generation 'molecular clamp' vaccine to a proof-of-concept human trial, after CEPI announced funding to support the technology.
